Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
About Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Actelion
1
Bial - Portela C S.A.
1
Institut de Recherches Internationales Servier
1
Clinical Trials at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
During the past decade, Instytut Psychiatrii i Neurologii II Klinika Neurologiczna conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on
average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
2008-12-02
2012-01-12
Completed
653
Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event
2016-12-19
2019-03-10
Completed
585
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
2017-03-30
2020-03-26
Terminated
136
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
2018-07-12
2025-08-26
Recruiting
1,500
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
2019-08-12
2028-04-04
Recruiting
1,000
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna"
#1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
According to Clinical.Site data, the most researched conditions in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" are
"Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Partial Epilepsy" (1 trials). Many other conditions were trialed in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" in a lesser frequency.
Clinical Trials Intervention Types at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
Most popular intervention types in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (6 trials), "Fenebrutinib" (3 trials), "Antihistamine" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
The vast majority of trials in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" are
11 trials for "All" genders.
Clinical Trials Status at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
Currently, there are NaN active trials in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna".
undefined are not yet recruiting,
7 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instytut Psychiatrii i Neurologii II Klinika Neurologiczna,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instytut Psychiatrii i Neurologii II Klinika Neurologiczna, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".